Application Detail
Description of Medical Service
The MBS item 73338 tests tumour tissue from a patient with metastatic colorectal cancer (stage IV) to determine if the requirements relating to rat sarcoma oncogene (RAS) gene mutation status for access to certain Pharmaceutical Benefits Scheme (PBS) medicines are fulfilled. This application seeks to amend item 73338 to include testing for BRAF V600 mutation status to determine eligibility for PBS access to encorafenib for metastatic colorectal cancer.Reason for Application
Amendment to MBS itemMedical Service Type
Co-dependent technologyPrevious Application Number/s
Not ApplicableAssociated Documentation
Application Form
Application Form (PDF 1197 KB)Application Form (Word 212 KB)
Consultation Survey
Consultation Survey (PDF 561 KB)Consultation Survey (Word 70 KB)
PICO Confirmation
PICO Confirmation (PDF 1245 KB)PICO Confirmation (Word 571 KB)
Assessment Report
-Public Summary Document
Public Summary Document (PDF 583 KB)Public Summary Document (Word 117 KB)